ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements with these filters
GPT Healthcare Limited held its 37th Annual General Meeting on August 6, 2026. Shareholders transacted ordinary and special business items as stated in the notice.
GPT Healthcare shows strong 18.2% revenue growth and 66% PAT growth, but struggles with utilization outside its core Kolkata market.
GPT Healthcare reported Q1 FY27 financial results. Total income grew 18% year-over-year to ₹128.2 Crore, reflecting steady operational performance.
GPT Healthcare reported Q1FY27 revenue of ₹126.2 Cr, up 17.8% YoY, with EBITDA margins improving to 20.4%. The company is executing a proximity-based model in Eastern India.
GPT Healthcare Ltd reported revenue from operations of ₹126.2 Cr (+17.8% YoY) and net profit of ₹12.7 Cr (+64.9% YoY) for Q1 FY27.
GPT Healthcare Limited has scheduled a board meeting for August 3, 2026, to consider and approve the company's unaudited financial results for the first quarter.
GPT Healthcare Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as required under SEBI regulations.
GPT Healthcare convened its 37th AGM for August 6, 2026. Key agendas include a Rs.1.50 final dividend declaration and director re-appointments.
GPT Healthcare Limited submitted its 37th Annual Report and AGM notice for FY 2025-26. The 37th Annual General Meeting is scheduled for August 6, 2026.
GPT Healthcare Limited filed its Annual Secretarial Compliance Report for the year ended March 31, 2026. The report confirms full regulatory compliance with no adverse observations.
GPT Healthcare reported Q4 FY26 revenue of ₹128cr (+24% YoY) and EBITDA margin of 19.5%. FY26 revenue stood at ₹478.5cr with an 18.8% margin.
GPT Healthcare delivered strong FY26 results with 24% YoY revenue growth in Q4, driven by the Raipur hospital scale-up and improved utilization in mature facilities like Salt Lake.
GPT Healthcare re-appointed its cost and internal auditors alongside several independent directors. These leadership and oversight renewals ensure regulatory compliance and operational continuity.
GPT Healthcare reported a 15.14% annual revenue growth to ₹478.5 Crore for FY26. Operational highlights include Raipur hospital commencement and 800+ robotic surgeries performed.
GPT Healthcare reported FY26 revenue of ₹478.5 Cr (up 15.1% YoY) and PAT of ₹42.2 Cr. Growth is driven by stronger clinical mix and the new Raipur hospital.
GPT Healthcare recommended a ₹1.50 per share final dividend for FY 2025-26. The record date is July 30, 2026, pending shareholder approval at the upcoming AGM.
GPT Healthcare Ltd reported revenue from operations of ₹126.4 Cr (+24.7% YoY) and net profit of ₹14.6 Cr (+13.2% YoY) for Q4 FY26.
GPT Healthcare reported a ₹42.72 Crore annual profit and recommended a ₹1.50 per share final dividend. Results show steady performance for the fiscal year ended 2026.
GPT Healthcare scheduled a board meeting on May 18, 2026. Directors will consider audited FY26 financial results and a potential final dividend recommendation.